Dupont J, Orgiazzi J, Burger A. [Autoimmune diseases and treatment with interferon-alpha: review of the literature apropos of a case of hyperthyroidism].
Rev Med Interne 1993;
14:93-9. [PMID:
8378632 DOI:
10.1016/s0248-8663(05)81258-5]
[Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
We report a case of thyrotoxicosis in a male patient under alpha-interferon (INF-alpha) therapy. Data from the literature show that treatment with IFN-a alone or combined with interleukin-2 (IL-2) can induce dysthyroidism (hypothyroidism, hyperthyroidism, thyroiditis). The frequency of dysthyroidism under INF-alpha therapy ranges from 10 to 40% depending on the authors. During combined INF-alpha and IL-2 therapy these figures reach 20 to 91%. The presence of anthyroid antibodies before treatment makes it more probable that dysthyroidism will occur. The administration of INF-alpha can exacerbate or induce various autoimmune diseases.
Collapse